BioStem Technologies, Inc.: updates and filings

BSEMNASDAQHealthcare · Biological Products, (No Diagnostic Substances)New listingsince Aug 6, 2026

Price

$0.98

November 17, 2026Market cap $19M

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 87 daysAround Feb 12, 2027 · for Q4 2026

last Nov 12, 2026next Feb 12, 2027

A rough estimate from when it has reported before, which has varied. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Nov 12, 2026 latest quarterly
  • Nov 12, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 12, 2026Results of operations
    Form8-K
  • Nov 10, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Nov 10, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Nov 5, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Oct 9, 2026Filing
    FormEFFECT
  • Oct 9, 2026Filing
    FormD
  • Oct 6, 2026Shares registered for employees
    FormS-8
  • Oct 2, 2026REGISTRATION STATEMENT
    FormS-1
  • Sep 30, 2026Material agreement entered, unregistered sale of shares, Regulation FD disclosure, other material events
    Form8-K
  • Sep 29, 2026Filing
    FormEFFECT
  • Sep 25, 2026Correspondence with the SEC
    FormCORRESP
  • Sep 25, 2026Letter from the SEC
    FormUPLOAD
  • Sep 21, 2026Filing
    FormD
  • Sep 18, 2026REGISTRATION STATEMENT
    FormS-1
  • Sep 18, 2026Material agreement entered, unregistered sale of shares, Regulation FD disclosure
    Form8-K
  • Aug 12, 2026Results of operations
    Form8-K
  • Aug 12, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Aug 11, 2026Filing
    FormEFFECT
  • Aug 7, 2026AMENDMENT NO. 1 TO FORM S-1 (amendment)
    FormS-1/A
  • Aug 7, 2026Other material events
    Form8-K
  • Aug 7, 2026Filing
    FormSEC STAFF ACTION
  • Aug 6, 2026Filing
    FormSEC STAFF LETTER
  • Aug 6, 2026Exchange certification of a listing
    FormCERT
  • Aug 4, 2026Correspondence with the SEC
    FormCORRESP

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 1, 2016.

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.